Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
NGEx Minerals Receives Court Approval for Valle Ancho Spin-Out

NGEx Minerals Receives Court Approval for Valle Ancho Spin-Out

MT newswireMT newswire2026/11/03 20:40
04:40 PM EST, 11/03/2026 (MT Newswires) -- NGEx Minerals (NGEX.TO) after trade Tuesday said it received final approval from the Supreme Court of British Columbia for its spin-out of the Valle Ancho Project into a wholly owned subsidiary, Valiente Resources. The transaction was also approved by shareholders on Oct. 29, it added. The company also said closing of the arrangement is set to occur effective as of 12:01 a.m. Vancouver time on Nov. 12. Under the arrangement, NGEx shareholders will receive one new NGEx share and one-fifth of a Valiente share for each NGEx share held, with no change to their existing ownership in NGEx, the company said. Following completion, shareholders will own all outstanding shares of Valiente, it added. Shares of NGEx Minerals closed up 2.9% at CA$20.85 on the Toronto Stock Exchange.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny